ANI PHARMACEUTICALS, INC Common Stock, Value, Outstanding
ANI PHARMACEUTICALS, INC (ANIP) had Common Stock, Value, Outstanding of $273.28 million as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Balance Sheet › Equity
us-gaap:CommonStockValueOutstanding · last filed 2013-05-10
- 2013-03-31: Common Stock, Value, Outstanding $273.28M.
- 2012-12-31: Common Stock, Value, Outstanding $273.13M.
- 2012-09-30: Common Stock, Value, Outstanding $273.26M.
- 2012-06-30: Common Stock, Value, Outstanding $265.77M.
| Period end | Common Stock, Value, Outstanding |
|---|---|
| 2013-03-31 | $273.28M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $273.13M 10-Q · filed 2013-05-10 |
| 2012-09-30 | $273.26M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $265.77M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $265.50M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $255.05M 10-K · filed 2013-02-28 |
| 2011-09-30 | $254.74M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $209.39M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $184.78M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |